Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05894967 · ClinicalTrials.gov registry record · NA
Moderators and Mediators of Perceptual Learning
A NA study of Cognitive Change, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 1,140
- Enrollment target
- 3
- Study locations
NCT05894967: Recruiting NA study of Cognitive Change, sponsored by University of Wisconsin, Madison.
NCT05894967 is a NA study of Cognitive Change that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 1,140 participants, above the 154-participant average among 44 other Cognitive Change trials with a reported enrollment target (640% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05894967, a NA study of Cognitive Change, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,140 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a research study about how training can impact performance on cognitive tasks. Participants are between 18 and 30 and 60 to 85 years of age, have normal (or corrected to normal) vision, and have no neurological conditions that would preclude their ability to complete computerized cognitive tasks. Up to 1140 participants will be on study for up to 8 weeks.
Primary Outcome
We will utilize an overarching task structure that allows us to assess learning on trained stimuli and transfer to untrained stimuli; locations, orientations, stimulus timings (e.g., we will assess contrast sensitivity for 6 different orientations). A trial begins with a fixation-point presented for 500ms. A target stimulus then appears for 128ms and then disappears (this timing was chosen to preclude participants making eye-movements to the stimuli). The participant is then required to respond
Conditions Studied
Interventions
- BEHAVIORAL C1 - Standard Perceptual Learning (SPL)
- BEHAVIORAL C2 - Long Training (LT)
- BEHAVIORAL C3 - Short Staircases (SS)
- BEHAVIORAL C4 - Mixed Difficulty (MD)
- BEHAVIORAL C5 - Noise Training (NT)
Study Locations (3)
California
- University of California - Riverside
Massachusetts
- Northeastern University - Boston
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,140 participants |
| Start Date | 2023-04-14 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT05894967 shows while recruiting
NCT05894967 is an interventional study that assigns participants to a tested intervention. Its 1,140 participants enrollment target places it among the larger protocols in the corpus, above the 154-participant average among 44 other Cognitive Change trials with a reported enrollment target (640% higher).
The record links to 1 condition, with Cognitive Change appearing as the primary indexed condition, and to 5 interventions - of which C1 - Standard Perceptual Learning (SPL) is the first listed.
NCT05894967 reports a single indexed study location in California, Massachusetts, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05894967 about?
NCT05894967 is a clinical study titled "Moderators and Mediators of Perceptual Learning". This is a research study about how training can impact performance on cognitive tasks. Participants are between 18 and 30 and 60 to 85 years of age, have normal (or corrected to normal) vision, and have no neurological conditions that would preclude their ability to complete computerized cognitive t...
What is the current status of trial NCT05894967?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,140 participants. The study started on 2023-04-14. Estimated completion is 2027-03-31.
What conditions does trial NCT05894967 study?
This clinical trial studies the following conditions: Cognitive Change.
What interventions are being tested in trial NCT05894967?
The interventions under investigation include: C1 - Standard Perceptual Learning (SPL) (BEHAVIORAL), C2 - Long Training (LT) (BEHAVIORAL), C3 - Short Staircases (SS) (BEHAVIORAL), C4 - Mixed Difficulty (MD) (BEHAVIORAL), C5 - Noise Training (NT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05894967?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05894967 being conducted?
This trial has 3 study locations across California, Massachusetts, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Change
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05894967's enrollment target sits among peer trials
1,140 2nd of 44 the highest of 44 other Cognitive Change trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Change trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Amplitude Titration to Improve ECT Clinical Outcomes
RECRUITING · NA
-
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
RECRUITING · NA
-
Remote Evaluation of MIND Diet
RECRUITING · NA
-
Cognitive Augmentation Via Multimodal Sensing and Auricular Neurostimulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI